MAM
LONA

Marquette Asset Management’s LeonaBio Inc LONA Stock Holding History

Marquette Asset Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,078
Closed -$62.2K – 204
2023
Q3 		$62.2K Buy
+3,078
New +$78.8K 0.01% 134

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Marquette Asset Management's LONA Position: Q4 2023 in Review

Marquette Asset Management sold out of LeonaBio Inc (LONA) in Q4 2023, closing a stake of 3,078 shares — an estimated $62.2K sold.

Marquette Asset Management first reported a position in LONA in Q3 2023 and held it in 1 quarter. The position peaked at $62.2K in Q3 2023. 65 funds tracked by Wall St. Rank hold LONA as of Q4 2023.

  • Marquette Asset Management reported no remaining LeonaBio Inc position as of Q4 2023 after selling out during the quarter.
  • Marquette Asset Management sold 3,078 LeonaBio Inc shares in Q4 2023, an estimated $62.2K.
  • Marquette Asset Management first reported a position in LeonaBio Inc in Q3 2023 and held it in 1 quarter.
  • Marquette Asset Management's LeonaBio Inc position peaked at $62.2K in Q3 2023.
  • 65 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2023.

Based on Marquette Asset Management's 13F filing for Q4 2023, filed 2 Feb 2024.